Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients

Inflamm Bowel Dis. 2011 Aug;17(8):E94-5. doi: 10.1002/ibd.21756. Epub 2011 May 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Azathioprine / therapeutic use
  • Biomarkers / blood
  • Cells, Cultured
  • Colitis, Ulcerative / blood
  • Colitis, Ulcerative / drug therapy
  • Colitis, Ulcerative / metabolism*
  • Crohn Disease / blood
  • Crohn Disease / drug therapy
  • Crohn Disease / metabolism*
  • Female
  • HLA-G Antigens / blood
  • HLA-G Antigens / drug effects*
  • HLA-G Antigens / metabolism*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Leukocytes, Mononuclear / metabolism
  • Male
  • Mesalamine / therapeutic use
  • Middle Aged

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents, Non-Steroidal
  • Biomarkers
  • HLA-G Antigens
  • Immunosuppressive Agents
  • Mesalamine
  • Azathioprine